Biology | Disease | Environmental | NIH
Lung development may explain why some non-smokers get COPD and some heavy smokers do not
On Jun. 9, 2020, people with small airways relative to the size of their lungs may have a…
-
-
Biotechnology | Diagnostics | Disease | FDA | Oncology | Therapeutics
FDA approved first targeted therapy to treat aggressive form of lung cancer
On May 6, 2020, the U.S. Food and Drug Administration (FDA) approved Tabrecta (capmatinib) for the treatment of…
-
Phase 3 trial of Libtayo (cemiplimab) as monotherapy for first-line advanced non-small cell lung cancer stopped early due to highly significant improvement in overall survival
On Apr. 27, 2020, Regeneron and Sanofi announced the primary endpoint of overall survival was met in a…
-
Biotechnology | Diagnostics | Disease | NIH | Oncology | Radiology | Vaccine
Winship Cancer Institute awarded prestigious Lung Cancer SPORE grant from NCI
On Jun. 10, 2019, the Winship Cancer Institute was awarded a five-year, $9.7 million Specialized Program of Research…
-
The National Cancer Institute awarded a $10.7 million grant to Abramson Cancer Center to study CAR T cells in solid tumors
On Oct. 22, 2018, the National Cancer Institute (NC) awarded a $10.7 million five year grant to Abramson…
-
The CPRIT awarded academic research and prevention grants totaling $73.5 million
On Feb. 21, 2018, the Cancer Prevention and Research Institute of Texas (CPRIT) awarded 49 new academic research…
-
Roswell Park study brought Cuban lung cancer vaccine to U.S. Patients
On Oct. 27, 2016, Roswell Park Cancer Institute announced it had received authorization from the U.S. Food and…
-
Biotechnology | Chemistry | Disease | FDA | Oncology | Therapeutics
Genentech drug Tecentriq (atezolizumab) was approved
On Oct. 18, 2016, the U.S. Food and Drug Administration (FDA) approved TECENTRIQ® (atezolizumab) for the treatment of…
-
Biotechnology | Diagnostics | FDA | Oncology | Therapeutics
Genentech drug Alecensa (alectinib) was approved by FDA
On Dec. 11, 2015, Genentech announced that it’s drug Alecensa (alectinib) was approved by the U.S. Food and…
-
Southwestern lung cancer researcher Dr John Minna named Giant of Cancer Care
On Oct. 6, 2015, Cancer biologist Dr. John Minna, with the Harold C. Simmons Comprehensive Cancer Center at…
-
Yale Cancer Center was awarded a SPORE grant for translational research in lung cancer
In 2015, Yale Cancer Center was awarded a SPORE (Specialized Programs of Research Excellence) grant for translational research…
-
Genetic region linked to a five times higher lung cancer risk
On Sept. 2008, a narrow region on chromosome 15 contains genetic variations strongly associated with familial lung cancer,…
-
Biotechnology | Diagnostics | Disease | Genomics | NIH | Oncology | Therapeutics | Women's Health
NIH announced two integral components of the Cancer Genome Atlas Pilot Project
On Oct. 16, 2006, the Cancer Genome Atlas program, created by National Cancer Institute and the National Human…
-
The Biomarkers Consortium was founded
On Oct. 5, 2006, the Foundation for the National Institutes of Health, NIH, FDA, and the Pharmaceutical Research…
-
The Winship Cancer Institute received a $7.9 million, 5-year grant from the NCI to study cell signaling in lung cancer
In 2006, the Winship Cancer Institute received a $7.9 million P01 5-year grant from the Cancer Institute (NCI)…
-
UW Doctor performed SCCA’s first video-assisted thoracic surgery
In 2005, Dr. Michael Mulligan from the University of Washington performed Seattle Cancer Care Alliance’s (SCCA) first video-assisted…
-
Biotechnology | Disease | FDA | Oncology | Therapeutics
Genentech drug Tarceva (erlotinib) was approved
On Nov. 18, 2004, the U.S. Food and Drug Administration (FDA) announced it had approved Genentech’s drug Tarceva…
-
Data from the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial was announced
On Jun. 5, 2003, data from the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial gave fresh insight…
-
NCI launched the National Lung Screening Trial to compare two ways of testing for early lung cancer in current and former heavy smokers
On Sept. 18, 2002, the National Cancer Institute launched the National Lung Screening Trial to compare two ways…
-
Emory University established the Tobacco Technical Assistance Consortium
On Feb. 11, 2002, three leading national health organizations announced they had committed $15 million to establish the…
-
The National Cancer Institute launched the National Lung Screening Trial
In 2002, the National Cancer Institute (NCI) launched the landmark National Lung Screening Trial (NLST) to determine whether…
-
Alpha-Tocopherol Beta-Carotene Cancer Prevention Study found no benefit from use of beta-carotene supplements
On Apr. 14, 1994, the Alpha-Tocopherol Beta-Carotene (ATBC) Cancer Prevention Study found no benefit from the use of…
-
The Priestley Medal was awarded to Howard E. Simmons
In 1994, the American Chemical Society awarded the Priestley Medal to Howard E. Simmons ‘for his numerous contributions…
-
Washington University School of Medicine announced as a participating site for the prostate, lung, colorectal, and ovarian cancers (PLCO study)
In 1993, the Washington University School of Medicine announced that it was a participating site for the prostate,…
-
Pacific Health Research Institute was awarded the multi-center ‘Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial’
In 1992, the National Cancer Institute (NCI) awarded the Pacific Health Research Institute its largest and most enduring…
-
The CDC established the Chronic Disease Division
In 1988, the U.S. Centers for Disease Control and Prevention (CDC) established the Chronic Disease Division to target…
-
Harcourt Sylvester Jr pledged $27.5 million to Sylvester Comprehensive Cancer Center
In 1986, philanthropist Harcourt Sylvester Jr. pledged $27.5 million to benefit cancer programs at the medical school, and…
-
Biotechnology | Diagnostics | Disease | Oncology | Radiology | Therapeutics
John Wayne Cancer Institute was founded
In 1981, John Wayne Cancer Institute (formerly known as the John Wayne Cancer Clinic) was founded to promote…
-
Biology | Diagnostics | Disease | FDA | Life Science History | Non-Profit Research | Oncology | Therapeutics
FDA approved Cisplatin, a platinum-containing anticancer compound
On Dec. 19, 1978, the U.S. Food and Drug Administration (FDA) approved cisplatin (Platinol) for use in combination…
-
The CDC became the home for the National Clearinghouse for Smoking and Health
In 1976, the U.S. Centers for Disease Control and Prevention (CDC) became the home for the National Clearinghouse…
